Squarepoint’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-99,372
| Closed | -$1.34M | – | 3242 |
|
|
2025
Q1 | $1.34M | Buy |
99,372
+66,121
| +199% | +$891K | ﹤0.01% | 1355 |
|
|
2024
Q4 | $637K | Sell |
33,251
-10,328
| -24% | -$198K | ﹤0.01% | 1804 |
|
|
2024
Q3 | $991K | Sell |
43,579
-99,357
| -70% | -$2.26M | ﹤0.01% | 1442 |
|
|
2024
Q2 | $1.86M | Buy |
142,936
+115,980
| +430% | +$1.51M | ﹤0.01% | 1094 |
|
|
2024
Q1 | $472K | Buy |
+26,956
| New | +$472K | ﹤0.01% | 1695 |
|
|
2023
Q4 | – | Sell |
-10,519
| Closed | -$161K | – | 3010 |
|
|
2023
Q3 | $161K | Buy |
+10,519
| New | +$161K | ﹤0.01% | 2172 |
|
|
2023
Q1 | – | Sell |
-17,207
| Closed | -$503K | – | 2835 |
|
|
2022
Q4 | $503K | Buy |
+17,207
| New | +$503K | ﹤0.01% | 1457 |
|
|
2022
Q2 | – | Sell |
-61,390
| Closed | -$1.14M | – | 2670 |
|
|
2022
Q1 | $1.14M | Buy |
+61,390
| New | +$1.14M | ﹤0.01% | 1074 |
|
|
2021
Q2 | – | Sell |
-11,668
| Closed | -$195K | – | 3067 |
|
|
2021
Q1 | $195K | Buy |
+11,668
| New | +$195K | ﹤0.01% | 2166 |
|
|
2020
Q3 | – | Sell |
-7,942
| Closed | -$132K | – | 2706 |
|
|
2020
Q2 | $132K | Buy |
7,942
+3,458
| +77% | +$57.5K | ﹤0.01% | 1879 |
|
|
2020
Q1 | $30K | Buy |
+4,484
| New | +$30K | ﹤0.01% | 1753 |
|
|
2018
Q2 | – | Sell |
-1,227
| Closed | -$129K | – | 2072 |
|
|
2018
Q1 | $129K | Buy |
1,227
+356
| +41% | +$37.4K | ﹤0.01% | 1546 |
|
|
2017
Q4 | $136K | Buy |
+871
| New | +$136K | ﹤0.01% | 1885 |
|